Starpharma (ASX:SPL) launches VivaGel in Europe - Sequoia Direct Pty Ltd

16JunJune 16, 2020

Starpharma (ASX:SPL) launches VivaGel in Europe

Starpharma (ASX:SPL) today announced that VivaGel BV has been launched in Central and Eastern European region.

This launch follows European launches in Germany, UK and several other European countries.

VivaGel BV is available Over-The-Counter in the region, without the need to see a doctor or obtain a prescription.

The region gives access to more than 45 million women and Mundipharma continues to rollout the product in the region.

VivaGel BV is a novel, non-antibiotic therapy for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV.

Shares in Starpharma (ASX:SPL) are trading 6.7 per cent higher at $1.03.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

22NovNovember 22, 2019

Comet Ridge (ASX:COI) looks to new deal to connect early gas

22 Nov 2019 - Comet Ridge’s (ASX:COI) Mahalo North Project is a step closer to market after the company signed a non-binding letter of intent with adjacent gas producer and infrastructure owner Denison Gas (Queensland) today.

22AprApril 22, 2020

SG Fleet Group (ASX:SGF) directors take 30% paycut

22 Apr 2020 - SG Fleet Group’s (ASX:SGF) Board of Directors and senior executives have reduced their pay by 30 per cent in efforts to manage the impact of COVID-19.

08JulJuly 8, 2022

Stocks of the Hour: TNG, Eastern Resources & Neometals

08 Jul 2022 - A snapshot of the stocks on the move featuring TNG Limited (ASX:TNG), Eastern Resources (ASX:EFE) & Neometals (ASX:NMT).

04MarMarch 4, 2020

Dexus (ASX:DXS) will cease the management of the Australian Mandate

04 Mar 2020 - Real estate group Dexus (ASX:DXS) will end the management of the Australian Mandate, comprising a $1.6 billion property portfolio from 30 June 2020.

15AprApril 15, 2021

92 Energy (ASX:92E) becomes first pure-play uranium to list on ASX

15 Apr 2021 - Uranium explorer 92 Energy (ASX:92E) has become the first high-grade unconformity type uranium producer to float shares on the Australian sharemarket in 10 years.

08AprApril 8, 2020

Cochlear (ASX:COH) sees FDA approval for Remote Check

08 Apr 2020 - Implantable hearing solutions company Cochlear (ASX:COH) has obtained US Food and Drug Administration (FDA) approval for its Remote Check solution.

11DecDecember 11, 2019

Centuria Industrial REIT (ASX:CIP) buys Arnott’s properties in Queensland

12 Dec 2019 - Centuria Industrial REIT (ASX:CIP) has acquired two industrial assets via a sale and leaseback with biscuit maker Arnotts for $236 million.

10SepSeptember 10, 2021

Stocks of the Hour: Woolworths, Santos & PolyNovo

10 Sep 2021 - A snapshot of the stocks on the move, featuring Woolworths (ASX:WOL), Santos (ASX:STO) and PolyNovo (ASX:PNV).

25MayMay 25, 2020

Ramsay (ASX:RHC) completes $300m share purchase plan

25 May 2020 - Ramsay Health Care has completed its $300 million share purchase plan (SPP) and will issue 5.37 million new shares.

18SepSeptember 18, 2020

Anglo (ASX:AAR) successfully completes $11M placement

18 Sep 2020 - Gold and base metals explorer Anglo Australian Resources (ASX:AAR) has received firm commitments for an $11 million single-tranche placement at $0.17.